GlobeNewswire
-
Senseonics and Beta Bionics Launch Eversense® 365 and iLet® Bionic Pancreas Integration
16/11/2026 -
Genelux Corporation Reports Third Quarter Financial Results and Provides Business Updates
16/11/2026 -
AEON Biopharma Reports Third Quarter 2026 Financial Results and Provides Corporate Update
16/11/2026 -
Precision Optics Reports First Quarter Fiscal 2027 Financial Results
16/11/2026 -
Olema Oncology to Participate in Upcoming Investor Conferences
16/11/2026 -
Traws Pharma Reports Third Quarter 2026 Financial Results and Provides Business Highlights
16/11/2026 -
Cue Biopharma Reports Third Quarter 2026 Financial Results and Recent Business Highlights
16/11/2026 -
IMDx Reports Third Quarter 2026 Results and Provides Corporate Update
16/11/2026 -
FDA approves Roche’s Wilserdly (giredestrant), a next-generation oral SERD, for ER-positive, ESR1-mutated advanced breast cancer
16/11/2026 -
New Five-Year Lecanemab Data from Clarity AD Study Long-Term Extension Presented at CTAD 2026
17/11/2026 -
Vivos Therapeutics Reports Third Quarter 2026 Financial Results and Provides Operational Update
17/11/2026 -
Ziphius, une société de biotechnologie de premier plan spécialisée dans l’ARN auto-amplificateur, annonce aujourd’hui la nomination de M. Antoon Loomans au sein de son conseil d’administration
17/11/2026 -
AGC Biologics Welcomes Multiple Cell Therapy Projects to New Yokohama Site
17/11/2026 -
NKGen Biotech Reports Long-Term Clinical Observations with Investigational Alzheimer’s Treatment Troculeucel at CTAD 2026
16/11/2026 -
Galimedix Therapeutics outlines development plans in Alzheimer's disease at CTAD 2026
16/11/2026 -
Exicure Announces Filing of Notification of Late Filing on Form 12b-25
16/11/2026 -
Rhythm Pharmaceuticals Announces Presentation of New Data at ObesityWeek® 2026
16/11/2026 -
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
16/11/2026 -
Stipple Bio Announces Multi-Target Multi-Modality Oncology Research Collaboration with Lilly
16/11/2026
Pages